Loading...
In silico and in vitro identification of inhibitory activities of sorafenib on histone deacetylases in hepatocellular carcinoma cells
Although sorafenib has been approved for treating hepatocellular carcinoma (HCC), clinical results are not satisfactory. Polypharmacology (one drug with multiple molecular targets) is viewed as an attractive strategy for identifying novel mechanisms of a drug and then rationally designing more-effec...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5689675/ https://ncbi.nlm.nih.gov/pubmed/29156785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21030 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|